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Abstract
Background: Attention deficit hyperactivity disorder (ADHD) is a complex neurobehavioral
disorder. The dopamine transporter gene (DAT1/SLC6A3) has been considered a good candidate
for ADHD. Most association studies with ADHD have investigated the 40-base-pair variable
number of tandem repeat (VNTR) polymorphism in the 3'-untranslated region of DAT1. Only few
studies have reported association between promoter polymorphisms of the gene and ADHD.
Methods: To investigate the association between the polymorphisms -67A/T (rs2975226) and -
839C/T (rs2652511) in promoter region of DAT1 in ADHD, two samples of ADHD patients from
the UK (n = 197) and Taiwan (n = 212) were genotyped, and analysed using within-family
transmission disequilibrium test (TDT).
Results: A significant association was found between the T allele of promoter polymorphism -67A/
T and ADHD in the Taiwanese population (P = 0.001). There was also evidence of preferential
transmission of the T allele of -67A/T polymorphism in combined samples from the UK and Taiwan
(P = 0.003). No association was detected between the -839C/T polymorphism and ADHD in either
of the two populations.
Conclusion: The finding suggests that genetic variation in the promoter region of DAT1 may be
a risk factor in the development of ADHD.
Background
Attention deficit hyperactivity disorder (ADHD) is a com-
mon and highly heritable neurodevelopmental disorder
that affects 3–10% of children and 2–4% of adults [1,2].
ADHD is characterized by inattention, hyperactivity and
impulsivity. Data from twin, adoption and family studies
show that ADHD is highly heritable, and that genetic var-
iation is likely to play a substantial role in the etiology of
the disorder [3]. Molecular genetic and pharmacological
studies suggest the involvement of the dopaminergic, ser-
otonergic and noradrenergic neurotransmitter systems in
the pathogenesis of ADHD. Polymorphic variants in sev-
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eral genes involved in regulation of the dopamine, and
related neurotransmitter pathways have been reported to
be associated with ADHD [3-6].
The dopamine transporter (DAT) plays a key role in the
regulation of dopaminergic neurotransmission by medi-
ating the active reuptake of synaptic dopamine. Several
lines of evidence implicate altered function of DAT in the
aetiology of ADHD. In particular, the DAT is a major tar-
get for various pharmacologically active stimulants,
including methylphenidate, which is one of the most
commonly prescribed treatments for ADHD.
Functional variants in the DAT1 gene have been widely
studied in aetiological studies of ADHD. Most association
studies between DAT1 and ADHD have concentrated on a
variable number of tandem repeat (VNTR) polymorphism
in the 3'-untranslated region of the gene. Cook et al. [7]
first reported an association between the 10-reapeat allele
of this polymorphism and ADHD, and several groups
subsequently replicated this finding [8-13], although such
replications are not ubiquitous and several studies have
failed to detect any association [14-21]. More recent stud-
ies have examined additional markers across the DAT1
gene, finding stronger evidence for an association with
multi-marker haplotypes containing the 10-repeat VNTR
allele [18,22]. The 10-repeat allele has been associated
with quantitative ADHD-trait scores in general popula-
tion samples [23,24], suggesting it may act as a quantita-
tive trait locus (QTL) influencing hyperactivity in the
normal range above and beyond its role as a risk for clin-
ical ADHD. The mechanism behind the reported associa-
tions is not yet understood, although several lines of
evidence implicate variation in gene expression [25,26].
Linkage disequilibrium does not extend across the entire
DAT1 gene, and recent evidence suggests the presence of
independent risk variants at the 5' end of the gene. Rubie
et al. [27] found four polymorphisms (-67A/T, -839C/T, -
1169C/G, -1476T/G), all in tight LD in the DAT1 pro-
moter region that are related to potential transcriptional
recognition sites. It is plausible that these polymorphisms
may be functional and thus potential candidates for a role
in ADHD. Recently, three studies have investigated several
of these promoter polymorphisms in clinical ADHD sam-
ples [20,28,29]. In a large study of 51 candidate genes,
Brookes et al [28] found nominal significance with one or
more SNPs in 18 genes, including -839C/T polymorphism
of DAT1, with the C allele being significantly over-trans-
mitted to affected ADHD probands (χ2 = 5.58, P = 0.018).
Genro et al. [20] also investigated this SNP in a sample of
243 Brazilian ADHD children and adolescents, and also
found a significant association for biased transmission of
the C allele to ADHD children (P = 0.03). Another study
examined the association between the DAT1 promoters -
67A/T polymorphism and ADHD in a case/control study,
finding a significant association with the T allele [29].
In this study we aimed to provide further clarification of
reported associations by genotyping two polymorphisms
in the DAT1 promoter region for association with ADHD
in two independent family-based clinical samples from
the UK and from Taiwan.
Methods
Sample characteristics
For the UK sample DNA was collected using buccal swabs
from 197 ADHD combined subtype probands, from both
parents in 133 families, and from only the mother in 64
families. One hundred and seventeen of the ADHD
probands had at least one sibling who was also geno-
typed. Cases were referred for assessment if they were
thought by experienced clinicians to have a diagnosis of
the combined subtype of ADHD under DSM-IV criteria,
with no significant Axis I co-morbidity apart from opposi-
tional defiant disorder (ODD) and conduct disorder (CD)
and IQ greater than 70. The age range was 5–15 years at
the time of assessment (mean 10.41, SD 2.34). Parents
were interviewed with a modified version of the Child and
Adolescent Psychiatric Assessment (CAPA) [30]. Informa-
tion on ADHD symptoms at school was obtained using
the long form of the Conner's questionnaire [31]. The
subjects gave their written informed consent, and this
study was approved by the Ethical Committee of King's
College London (Reference number: G9814668).
The Taiwanese sample consisted of 212 children with
ADHD diagnosed between the ages of 5–15 years (mean
8.96, SD 2.60). Both parents were available for 114 fami-
lies, only the mother for 59 families and only the father
for 39 families. ADHD cases were ascertained from the
Child Psychiatric Clinics in the Chang Gung Memorial
Hospital in Taipei area, Taiwan. A diagnosis of ADHD was
made according to DSM-IV criteria following completion
of a standard maternal interview [32], and completion of
parent and teacher Conner's revised rating scales [31].
Autism cases were excluded from the study. No other neu-
rological or behavioural disorders were identified. Sub-
jects gave their written informed consent, and were
approved by the Institutional Review Board, Chang Gung
Memorial Hospital, Taiwan (Reference number: 94-471
and 96-0058B).
Molecular genetics
The -67A/T (rs2975226) and -839C/T (rs2652511) poly-
morphisms were genotyped using PCR and enzyme diges-
tion. For the -67A/T SNP the genomic DNA was amplified
using forward primers 5'CCAGCCATCTGCGTCC-3'
(spanning nucleotide position -151 to -135) and reverse
primers 5'-GATGCCGAGAGCGACG-3' (spanning nucle-BMC Psychiatry 2009, 9:3 http://www.biomedcentral.com/1471-244X/9/3
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otide position +98 to +113). For the -839C/T SNP the PCR
was performed using forward primers 5'GCTCACG-
GGAGCATCGAG-3' (spanning nucleotide position -973
to -956) and reverse primers 5'-GCACTCGCCTAA-
GAAAACCA-3' (spanning nucleotide position -689 to -
708). After amplification of genomic DNA the PCR prod-
uct were digested with restriction enzyme Tth111I (for -
67A/T SNP) and MspI (for -839C/T SNP) (New England
Biolabs). The detail protocols were described in previous
study [27].
Statistical analysis
Family genotype data were analysed using the transmis-
sion disequilibrium test (TDT) implemented in
UNPHASED program (TDTPHASE) [33], http://
www.mrc-bsu.cam.ac.uk/personal/frank/software/
unphased/. Linkage disequilibrium (LD) was estimated
by calculating D' and r2 statistics. The Bonferroni correc-
tion was applied for multiple comparisons and P < 0.0125
was considered to show a statistically significant differ-
ence.
Results
Population frequencies for the two markers were esti-
mated from parental genotypes. For the UK and the Tai-
wanese sample the A-allele frequency of the -67A/T
polymorphism is 61% and 68%, respectively, and the C-
allele frequency of the -839C/T polymorphism is 52% and
53%, respectively. Allele frequencies of both markers did
not show any significant deviation from those expected
according to Hardy -Weinberg equilibrium in either pop-
ulation. Significant LD was observed between the two
markers (D' = 1, r2 = 0.91 in UK samples; D' = 0.70, r2 =
0.59 in Taiwanese samples).
TDT analysis (Table 1) showed that the T allele of the -
67A/T polymorphism was significantly over-transmitted
to affected probands in the Taiwanese population (χ2 =
10.43, P = 0.001, odds ratio = 1.8). Even after correcting
P- values using the Bonferroni method for multiple com-
parisons a significant association was still found between
the -67T allele and ADHD cases in Taiwanese population.
No significant association was seen in the UK sample for
this marker using either standard TDT analysis, or the
extended TDT analysis including siblings, although the T-
allele was over-transmitted (OR = 1.16). A combined
analysis including both population samples found signif-
icant association of the T-allele (χ2 = 8.56, P = 0.003, OR
= 1.5). No difference in the transmission of any alleles of
the -839C/T polymorphism to ADHD was found in either
of the two populations (Table 2).
Haplotype analysis revealed that the haplotype -67T/-
839T was significantly over-transmitted to the Taiwanese
ADHD probands and combined UK and Taiwanese sam-
ples (χ2 = 12.47, P = 0.0004 in Taiwanese samples; χ2 =
8.49, P = 0.004 in combined samples), while haplotype -
67A/-839T was significantly under-transmitted to Taiwan-
ese ADHD probands and combined samples (χ2 = 13.13,
P = 0.0003 in Taiwanese samples; χ2 = 10.58, P = 0.001 in
combined samples) (Table 3).
Discussion
In this study, we set out to investigate previously reported
findings of association between the two promoter poly-
morphisms of the DAT1gene in two independent samples
of ADHD probands from UK and Taiwan. We found a sig-
nificant over-transmission of the -67T allele to ADHD
combined subtype cases in Taiwanese population and the
two combined samples from UK and Taiwan. Our study
replicates a finding conducted by Ohadi et al. [29], who
found that the T allele of -67A/T polymorphism was over-
represented (around 1.6 fold excess) in the ADHD
probands compared to controls (χ2 = 14.50, P < 0.001) in
Table 1: TDT Analysis of the DAT1 Promoter -67A/T Polymorphism
UK samples Allele Taiwanese samples Allele Combined samples Allele
AT A T A T
Transmitted 37 43 45 81 82 124
Non-transmitted 43 37 81 45 124 82
χ2, df (P-value) 0.45, 1 df (0.502) 10.43, 1 df (0.001) 8.56, 1 df (0.003)
Table 2: TDT Analysis of the DAT1 Promoter -839C/T Polymorphism
UK samples Allele Taiwanese samples Allele Combined samples Allele
CT C T C T
Transmitted 50 49 40 55 90 104
Non-transmitted 49 50 55 40 104 90
χ2, df (P-value) 0.01, 1 df (0.919) 2.38, 1 df (0.123) 1.01, 1 df (0.315)BMC Psychiatry 2009, 9:3 http://www.biomedcentral.com/1471-244X/9/3
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an Iranian sample. We did not observe any association
with the -839C/T polymorphism and ADHD in either of
our samples, and were thus unable to replicate the find-
ings by Brookes et al [28] and Genro et al. [20]. In this
study there were no effects at all on the two markers in the
UK samples. However, haplotype analysis demonstrated
significant preferential transmission of the -67T/-839T
haplotype in the Taiwanese ADHD sample and the com-
bined UK and Taiwanese samples. In addition, haplotypes
-67A/-839T were under-transmitted to Taiwanese ADHD
probands and combined samples.
Conclusion
In conclusion, in this study we used family-based ADHD
data in the UK and Taiwanese population to test for an
association between two SNP variants in the promoter
region of DAT1 and susceptibility to the disorder. Our
findings support the notion that genetic variation in the
promoter region of DAT1 might be a risk factor in the
development of ADHD, particularly in the Taiwanese
sample studied. Whilst further studies are needed to con-
firm these findings, our data suggest that association stud-
ies of DAT1 in ADHD should not be limited to variation
at the 3' end of the gene, which has been the traditional
focus for aetiological studies.
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